Create a narrative

Zymeworks Community

NasdaqGS:ZYME Community

1 Narratives written by author
0 Comments on narratives written by author
7 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 9 Analysts

Ziihera Launch And ZW251 IND Submission Will Broaden Treatment Options

Key Takeaways Strategic focus on advanced programs and cost management aims to enhance resource efficiency and net margins through promising returns. Expansion into autoimmune and inflammatory diseases enables market diversification and long-term earnings stability, leveraging existing technologies.

US$25.97

FV

44.9% undervalued

16.88%

Revenue growth p.a.

0

0

6

6 days ago